Last reviewed · How we verify
Timolol Maleate 0.5% Oph Soln
Timolol Maleate 0.5% Oph Soln is a Small molecule drug developed by XiaoXi Lin. It is currently in Phase 2 development. Also known as: 0.5% Timolol Maleate Drops.
At a glance
| Generic name | Timolol Maleate 0.5% Oph Soln |
|---|---|
| Also known as | 0.5% Timolol Maleate Drops |
| Sponsor | XiaoXi Lin |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Timolol Maleate 0.5% Oph Soln CI brief — competitive landscape report
- Timolol Maleate 0.5% Oph Soln updates RSS · CI watch RSS
- XiaoXi Lin portfolio CI
Frequently asked questions about Timolol Maleate 0.5% Oph Soln
What is Timolol Maleate 0.5% Oph Soln?
Timolol Maleate 0.5% Oph Soln is a Small molecule drug developed by XiaoXi Lin.
Who makes Timolol Maleate 0.5% Oph Soln?
Timolol Maleate 0.5% Oph Soln is developed by XiaoXi Lin (see full XiaoXi Lin pipeline at /company/xiaoxi-lin).
Is Timolol Maleate 0.5% Oph Soln also known as anything else?
Timolol Maleate 0.5% Oph Soln is also known as 0.5% Timolol Maleate Drops.
What development phase is Timolol Maleate 0.5% Oph Soln in?
Timolol Maleate 0.5% Oph Soln is in Phase 2.
Related
- Manufacturer: XiaoXi Lin — full pipeline
- Also known as: 0.5% Timolol Maleate Drops
- Compare: Timolol Maleate 0.5% Oph Soln vs similar drugs
- Pricing: Timolol Maleate 0.5% Oph Soln cost, discount & access